Cleveland Clinic
Cleveland, Ohio, 44195, United States
NCT Number: NCT00593359
This study will compare the effect of two intravenous solutions on eye pressure during spine surgery in the following groups:
Group A - Lactated Ringer's replacement for blood loss and placebo eye drops
Group B - Lactated Ringer's replacement for blood loss and brimonidine eye drops
Group C - Albumin replacement for blood loss and placebo eye drops
Group D - Albumin replacement for blood loss and brimonidine eye drops
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Cleveland, Ohio, 44195, United States
Patients will be administered either brimonidine eye drops, or placebo eye drops, preoperatively, on the day of surgery and during surgery. Eye pressure will be measured before surgery, every 30 minutes throughout your surgery and every hour for 4 hours following surgery. Subjects will be evaluated before surgery and on days 5, 8, 15 after surgery. During these evaluations, the subject will be asked questions about recovery and his/her eyes will be checked by an ophthalmologist and vision will be tested.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 15 days post surgery
Time frame: 15 days post surgery
The Cleveland Clinic
Other
The Effect of Lactated Ringer's Solution Versus Albumin and the Alpha-2 Agonist Brimonidine Versus Placebo on Intraocular Pressure During Prone Spine Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04281017
Intraocular Pressure, Neoplasms
Gainesville, Florida, United States
View Trial DetailsNCT07274176
Intraocular Pressure
Uşak, Turkey (Türkiye)
View Trial DetailsNCT07701278
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Banhā, Benha, Egypt
View Trial DetailsNCT07604428
Apnea, Eye Diseases
Olomouc, Czechia
View Trial Details